Vital SignsVital SignsCheck your MP →
RGJulie R. Gralow, MD — no licensed photograph is available, so the academic plate is shown instead.

Academic

Julie R. Gralow, MD

Chief medical officer and executive vice president of ASCO

Press citations

2

Topic

1

Cancer

Last quoted

Sept 2026

Julie R. Gralow, MD: key facts

Kind of voice
Academic
Role
Chief medical officer and executive vice president of ASCO
Quoted on
Cancer
Press citations held
2
Most recently quoted
30 Sept 2026

“Called the results not just a home run but "a grand slam" for both patients and investigators.”

What Julie R. Gralow, MD has said

  • “We suggest practices transition away from isolated 'bedside rationing,' where individual doctors are forced to make immediate choices between their own patients, toward a unified, proactive, and equitable system.”

    Chief Medical Officer of the American Society of Clinical Oncology (ASCO) · Cancer · 30 Sept 2026 · “This Is a Problem”: Oncologists Concerned Over Chemotherapy Shortages ↗

Where Julie R. Gralow, MD has been quoted

  1. Daraxonrasib Doubles Survival in Pancreatic Cancer at ASCO 2026: A Game-Changeroncologynewscentral.com · 30 Sept 2026
  2. “This Is a Problem”: Oncologists Concerned Over Chemotherapy Shortagesoncologynewscentral.com · 30 Sept 2026

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 30 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.